02.12.2024 • News

Hovione Expands Spray Drying Capacities in the USA and Ireland

Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.

The investment in New Jersey is the first step of a multi-year site expansion program, aimed at advancing both spray drying and tableting capabilities, Hovione said. Simultaneously, the spray drying capacity at the Cork facility was increases nearly twofold.

Jean-Luc Herbeaux, CEO of Hovione said: “These expansions, incorporating our latest technologies, reflect Hovione’s unwavering commitment to innovation and manufacturing service excellence. Strengthening our facilities and teams in the USA and Ireland allows us to better serve our customers and provide flexible supply options for both small- and large-scale programs. By increasing our capacity and enhancing our technological capabilities, we are even better equipped to help our customers bring new and more complex drugs to market.”

According to Hovione, the investments at both sites are part of the company’s long-term strategy to remain at the forefront of pharmaceutical technology.

© werbefoto-burger.ch – stock.adobe
© werbefoto-burger.ch – stock.adobe

Company

Hovione

Sete Casas
2674-506 Loures
Portugal

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read